Sulfasalazine-induced fulminant hepatic failure.

Hepatic regeneration: implications in fulminant hepatic failure.

Orlistat-induced fulminant hepatic failure.

Continuous haemoperfusion for fulminant hepatic failure.

Multimodal brain monitoring in fulminant hepatic failure.

Plasma prostaglandins in fulminant hepatic failure.

Artificial liver support in fulminant hepatic failure.

Haemofiltration in patients with fulminant hepatic failure.

The brain in fulminant hepatic failure.

Heroic treatment for fulminant hepatic failure?

New therapeutic aspects in fulminant hepatic failure.

Hepatitis C virus in fulminant hepatic failure.

Pharmacokinetics of flumazenil in fulminant hepatic failure.

Animal models of fulminant hepatic failure.

Fulminant hepatic failure secondary to primary hepatic angiosarcoma.

Pathogenesis of renal failure in cirrhosis and fulminant hepatic failure.

Anti-inflammatory effect of recombinant thrombomodulin for fulminant hepatic failure.

Fulminant hepatic failure of autoimmune aetiology in children.

Fulminant hepatic failure in the context of reinstituting valproate use.

Elevated brain concentrations of 1,4-benzodiazepines in fulminant hepatic failure.

Fulminant hepatic failure due to metastatic choroidal melanoma.

Acid-base and metabolic disturbances in fulminant hepatic failure.

Intestinal dendritic cells change in number in fulminant hepatic failure.

Fulminant liver failure model with hepatic encephalopathy in the mouse.

Structural alterations to the pulmonary circulation in fulminant hepatic failure.

Suggest Documents

Hepatic regeneration: implications in fulminant hepatic failure.

Orlistat-induced fulminant hepatic failure.

Continuous haemoperfusion for fulminant hepatic failure.

Multimodal brain monitoring in fulminant hepatic failure.

Plasma prostaglandins in fulminant hepatic failure.

Artificial liver support in fulminant hepatic failure.

Haemofiltration in patients with fulminant hepatic failure.

The brain in fulminant hepatic failure.

Heroic treatment for fulminant hepatic failure?

New therapeutic aspects in fulminant hepatic failure.

Hepatitis C virus in fulminant hepatic failure.

Pharmacokinetics of flumazenil in fulminant hepatic failure.

Animal models of fulminant hepatic failure.

Fulminant hepatic failure secondary to primary hepatic angiosarcoma.

Pathogenesis of renal failure in cirrhosis and fulminant hepatic failure.

Anti-inflammatory effect of recombinant thrombomodulin for fulminant hepatic failure.

Fulminant hepatic failure of autoimmune aetiology in children.

Fulminant hepatic failure in the context of reinstituting valproate use.

Elevated brain concentrations of 1,4-benzodiazepines in fulminant hepatic failure.

Fulminant hepatic failure due to metastatic choroidal melanoma.

Acid-base and metabolic disturbances in fulminant hepatic failure.

Intestinal dendritic cells change in number in fulminant hepatic failure.

Fulminant liver failure model with hepatic encephalopathy in the mouse.

Structural alterations to the pulmonary circulation in fulminant hepatic failure.

Sulfasalazine-induced fulminant hepatic failure.

Recommend Documents

Follow Us